Skip to main content

Table 3 The association between the molecular subtypes of the primary tumours and chemotherapy response rates

From: Association between gene expression profile of the primary tumor and chemotherapy response of metastatic breast cancer

  Response Molecular subtype
Basal Luminal A Luminal B HER2
N % N % N % N %
A-CT no 5 62,5% 12 48,0% 8 50,0% 2 28,6%
yes 3 37,5% 13 52,0% 8 50,0% 5 71,4%
NA/NT-CT no 5 83,3% 12 75,0% 9 75,0% 2 66,7%
yes 1 16,7% 4 25,0% 3 25,0% 1 33,3%
    0   0   0  
T-CT no 9 90,0% 4 36,4% 10 83,3% 2 66,7%
yes 1 10,0% 7 63,6% 2 16,7% 1 33,3%
  1. Abbreviations: A-CT anthracycline containing chemotherapy, NA/NT-CT non-anthracyline/non-taxane containing chemotherapy, T-CT taxane containing chemotherapy